This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Ventus Therapeutics U.s., Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ramsay Beveridge: Innovator in Pyridazine Compounds
Introduction
Ramsay Beveridge is a notable inventor based in Pointe-Claire, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific proteins involved in various diseases.
Latest Patents
Ramsay holds a patent for Pyridazine compounds for inhibiting NLRP3. This patent focuses on inhibitors of NLRP3, which are useful in the treatment of diseases and disorders associated with this protein. The compounds are characterized by a specific chemical formula, which enhances their efficacy in therapeutic applications.
Career Highlights
Ramsay Beveridge is currently associated with Ventus Therapeutics U.S., Inc., where he continues to innovate and develop new therapeutic solutions. His work is pivotal in advancing the understanding and treatment of diseases linked to NLRP3.
Collaborations
Ramsay has collaborated with talented professionals in his field, including Stéphane Dorich and Jason Burch. These collaborations have fostered a productive environment for research and development.
Conclusion
Ramsay Beveridge's contributions to the field of pharmaceuticals, particularly through his patent on Pyridazine compounds, highlight his role as an innovator. His ongoing work at Ventus Therapeutics U.S., Inc. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile